Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pharmather Holdings Ltd PHRRF


Primary Symbol: C.PHRM

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more

Bullboard (CSE:PHRM)

View:
Post by cool888on Feb 04, 2021 9:43am

$PHRM - Update ($$$$$)

https://stockhouse.com/news/press-releases/2021/02/04/pharmather-announces-successful-completion-of-pre-ind-meeting-with-fda-for-the
Post by Iconic25on Feb 04, 2021 8:44am

Magic Mushrooms

Sponsored post: "Magic Mushrooms" have long, slender stems which may appear white or greyish topped by caps with dark gills on the underside. Read this to understand about magic muchrooms, ...more  
Post by AwareInvestoron Feb 04, 2021 8:28am

PharmaTher To Commence Phase 2 Clinical Study On Ketamine In

Pharmather is successfully progressing on the development of its proposed phase 2 clinical study on ketamine in the use of levodopa-induced dyskinesia in patients with Parkinson’s disease. The company ...more  
Post by amp007Con Feb 04, 2021 8:23am

News

GLOBENEWSWIRE PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease   02/04/2021 8:00:00 AM ...more  
Comment by 19LDS84on Feb 03, 2021 9:57pm

RE:How much cash does the company have?

Yes very quite. Not sure why though. I feel like this company is way undervalued. Probably a good thing I suppose. They need some good PR. to get things moving
Post by cool888on Feb 03, 2021 7:03pm

$PHRM - Corporate Deck (Feb 2021)

https://www.pharmather.com/uploads/1/2/5/8/125844350/deck_-_phrm_-_1020201.pdf
Comment by amp007Con Feb 01, 2021 12:47pm

RE:PharmaTher Licenses Patented Microneedle Delivery Tech For K

I'm quite happy about this, because it is easy to see what the company is doing. These aren't arbitrary moves, and they seem to have a firm grasp on what they want to accomplish. Happy to be a ...more  
Post by AwareInvestoron Feb 01, 2021 8:14am

PharmaTher Licenses Patented Microneedle Delivery Tech For K

PharmaTher this morning announced that it has entered into an exclusive worldwide patent and know-how license agreement with that of the The Queen’s University of Belfast. The arrangement pertains to ...more  
Post by amp007Con Feb 01, 2021 7:47am

Premarket looks great...

Still early, but the premarket is looking great so far. I'm hoping it stays this way, or goes even higher. 
Post by amp007Con Jan 28, 2021 1:22pm

I picked up some more at .365

Here's hoping that was the bottom of the barrel...
Post by cool888on Jan 22, 2021 11:10am

$RVV $RVVTF - ETF ($$$$$)

https://stockhouse.com/news/press-releases/2021/01/22/revive-therapeutics-included-in-first-psychedelic-exchange-traded-fund
Comment by amp007Con Jan 21, 2021 10:19am

RE:$$RVV $RVVTF - Update ($$$$$)

Shouldn't this boost Phrm by contrast?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities